The effects of angiotensin-converting enzyme inhibition on endothelial dysfunction: Potential role in myocardial ischemia

American Journal of Cardiology

Volumn 82, Issue 9 SUPPL. 2, 1998, Pages 23S-27S

  Pepine, Carl J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ATENOLOL; BENAZEPRIL; CAPTOPRIL; CARVEDILOL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRILAT; IMIDAPRIL; LISINOPRIL; LOSARTAN; NIFEDIPINE; PERINDOPRIL; QUINAPRIL; QUINAPRILAT; TEMOCAPRIL;

BLOOD FLOW VELOCITY; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; DRUG EFFECT; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR ENDOTHELIUM;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; MYOCARDIAL ISCHEMIA;

EID: 0032548096     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00805-4     Document Type: Article

References (43)

1. Meredith IT, Yeung AC, Weidinger FF, Anderson TJ, Uehata A, Ryan TJ Jr, Selwyn AP, Ganz P. Role of impaired endothelium-dependent vasodilation in ischemic manifestations of coronary artery disease. Circulation 1993;87(suppl V):V56-V66.
2. Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993;22(suppl 4):S1-S14.
3. Hasdai D, Gibbons RJ, Holmes DR Jr, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997;96:3390-3395.
4. Vane JR, Anggard EE, Botting RM. Regulatory function of the vascular endothelium. N Engl J Med 1990;323:27-36.
5. Lüscher TF. Angiotensin, ACE-inhibitors and endothelial control of vasomotor tone. Basic Res Cardiol 1993;88(suppl I): 15-24.
6. Davies MK. Effects of ACE inhibitors on coronary haemodynamics and angina pectoris. Br Heart J 1994;72(suppl):52-56.
7. Shen W, Hintze TH, Wolin MS. Nitric oxide: an important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation 1995;92:3505-3512.
8. Yusuf S, Pepine CJ, Garces C, Pouleur H, Salem D, Kostis J, Benedict CM, Rousseau M, Bourassa M, Pitt B. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992;340:1173-1178.
9. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM, on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327:669-677.
10. Dzau VJ, Re R. Tissue angiotensin system in cardiovascular medicine: a paradigm shift? Circulation 1994;89:493-498.
11. Gibbons GH. Mechanisms of vascular remodeling in hypertension: role of autocrine-paracrine vasoactive factors. Curr Opin Nephrol Hypertens 1995;4: 189-196.
12. Diet F, Pratt RE, Berry GJ, Momose N, Gibbons GH, Dzau VJ. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 1996;94:2756-2767.
13. Zhang X, Xie Y-W, Nasjletti A, Xu X, Wolin MS, Hintze TH. ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation 1997;95:176-192.
14. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II mediated hypertension in the rat increases vascular Superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest 1996;97:1916-1923.
15. Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation 1997;96:3264-3265.
16. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;92:1355-1374.
17. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340: 1111-1115.
18. Latini R, Maggioni AP, Flather M, Sleight P, Tognoni G. ACE-inhibitor use in patients with myocardial infarction: summary of evidence of clinical trials. Circulation 1995;92:3132-3137.
19. van den Heuvel AFM, van Gilst WH, van Veldhuisen DJ, De Vries RJM, Dunselman PHJM, Kingma JH, for the Captopril and Thrombolysis Study (CATS) Investigators. Long-term anti-ischemic effects of angiotensin-converting enzyme inhibition in patients after myocardial infarction. J Am Coll Cardiol 1997;30:400-405.
20. Virdis A, Ghiadoni L, Lucarini A, Di Legge V, Taddei S, Salvetti A. Presence of cardiovascular structural changes in essential hypertensive patients with coronary microvascular disease and effects of long-term treatment. Am J Hypertens 1996;9:361-369.
21. Nakamura M, Funakoshi T, Yoshida H, Arakawa N, Suzuki T, Hiramori K. Endothelium-dependent vasodilation is augmented by angiotensin converting enzyme inhibitors in healthy volunteers. J Cardiovasc Pharmacol 1992;20:949-954.
22. Lyons D, Webster J, Benjamin N. Effect of enalapril and quinapril on forearm vascular ACE in man. Eur J Clin Pharmacol 1997;51:373-378.
23. Hornig B, Kohler C, Drexler H. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation 1997; 95:1115-1118.
24. Asmar RG, Pannier B, Santoni JP, Laurent S, London GM, Levy BI, Safar ME. Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation 1988;78:941-950.
25. Hirooka Y, Imaizumi T, Masaki H, Ando S, Harada S, Momohara M, Takeshita A. Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Hypertension 1992;20:175-180.
26. Creager MA, Roddy M-A. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension 1994;24:499-505.
27. Schiffrin EL, Deng LY. Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients. Hypertension 1995;25:699-703.
28. Antony I, Lerebours G, Nitenberg A. Angiotensin-converting enzyme inhibition restores flow-dependent and cold presser test-induced dilations in coronary arteries of hypertensive patients. Circulation 1996;94:3115-3122.
29. Kiowski W, Linder L, Nuesch R, Martina B. Effects of cilazapril on vascular structure and function in essential hypertension. Hypertension 1996;27:371-376.
30. Iwatsubo H, Nagano M, Sakai T, Kumamoto K, Morita R, Higaki J, Ogihara T, Hata T. Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension. Hypertension 1997;29:286-290.
31. Rizzoni D, Muiesan ML, Porteri E, Castellano M,Zulli R, Bettoni G, Salvetti M, Monteduro C, Agabiti-Rosei E. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens 1997;15:197-204.
32. Tomiyama H, Kimura Y, Mitsuhashi H, Kinouchi T, Yoshida H, Kushiro T, Doba N. Relationship between endothelial function and fibrinolysis in early hypertension. Hypertension 1998;31:321-327.
33. Higashi Y, Oshima T, Sasaki S, Nakano Y, Kambe M, Matsuura H, Kajiyama G. Angiotensin-converting enzyme inhibition, but not calcium antagonism, im-proves a response of the renal vasculature to L-arginine in patients with essential hypertension. Hypertension 1998;32:16-24.
34. Bijlstra PJ, Smits O, Lutterman JA, Thien T. Effect of long-term angiotensin-converting enzyme inhibition on endothelial function in patients with the insulin-resistance syndrome. J Cardiovasc Pharmacol 1995;25:658-664.
35. Nielsen FS, Rossing P, Gall MA, Smidt UM, Chen JW, Sato A, Parving HH. Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy. Scand J Clin Lab Invest 1997;57:427-434.
36. Giugliano D, Marfella R, Acampora R, Giunta R, Coppola L, D'Onofrio F. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension. Diabetes Care 1998;21:631-636.
37. Strikwerda S, Di Mario C, Gil R, Azar A, Ramos A, Serruys PW. Influence of long-term cilazapril treatment on endothelium-dependent coronary vasomotion in patients with coronary artery disease: a double-blind, placebo-controlled study. Eur Heart J 1994;15(suppl):429.
38. Mancini GBJ, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Garere RG, Wargovich TJ, Mudra H, Loscher TF, Klibaner MI, Haber HE, Uprichard ACG, Pepine CJ, Pitt B. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND (Trial on Reversing ENdothelial Dysfunction) study. Circulation 1996;94:25-265.
39. Prasad A, Husain S, Mincemoyer R, Panza A, Cannon RO, Quyyumi AA. Coronary endothelial dysfunction in humans improves with angiotensin converting enzyme inhibition. Circulation 1996;94(suppl):-61.
40. Anderson TJ, Overhiser RW, Haber H, Charbonneau F. A comparative study of four anti-hypertensive agents on endothelial function in patients with coronary disease. J Am Coll Cardiol 1998;31(suppl A):327A.
41. Hernandez E, Toledo T, Alamo C, Mon C, Rodicio JL, Praga M. Elevation of von Willebrand factor levels in patients with IgA nephropathy: effect of ACE inhibition. Am J Kidney Dis 1997;30:397-403.
42. Mullen MJ, Clarkson P, Donald AE, Thompson H, Thorne SA, Powe AJ, Furuno T, Bull T, Deanfield JE. Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: a randomized, double-blind study. J Am Coll Cardiol 1998;31:1330-1335.
43. Schlaifer JD, Wargovich TJ, O'Neill B, Mancini GBJ, Haber HE, Pitt B, Pepine CJ, on behalf of the TREND Investigators. Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. Am J Cardiol. 1997;80:1594-1597.